INCLINE VILLAGE, Nev. (AP) _ PDL BioPharma Inc. (PDLI) on Wednesday reported a second-quarter loss of $112.3 million, after reporting a profit in the same period a year earlier.
The Incline Village, Nevada-based company said it had a loss of 76 cents per share. Earnings, adjusted for one-time gains and costs, were 10 cents per share.
The biotechnology company posted revenue of $46.6 million in the period.
In the final minutes of trading on Wednesday, the company's shares hit $2.53. A year ago, they were trading at $2.64.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PDLI at https://www.zacks.com/ap/PDLI